WCC-2022

★ Scientific Program

Preliminary Program

Track 1-3: Cellular and Molecular Biology of Cancer

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Amanita Phalloides Avoids Tumor Growth of Leukocytes with Philadelphia Chromosome (Ph1) Dr. Isolde Riede, Senior Scientist, Independent Cancer Research, Germany
09:30-09:55		Title: Long non-coding RNA Steroid Receptor Activator Promotes the Progression of Ovarian Cancer by Targeting the Notch Signaling Pathway Dr. Hee Jung Kim, Associate Professor, The Catholic University of Korea, South Korea
09:55-10:20		Title: MiRNAs to Counteract Radioresistance of Lung Cancer Cells Dr. Mognato Maddalena, Università di Padova, Italy
10:20-10:45		Title: Hemolymph Fraction from R. venosa Exhibits Antiproliferative Effects in vitro Dr. Tsvetina Stoyanova, Bulgarian Academy of Sciences, Bulgaria
10:45-11:00	Coffee Break
11:00-11:25		Title: TBD Dr. Iva Ugrinova, Director, “Roumen Tsanev“ Institute of Molecular Biology, Bulgarian Academy of Sciences, Bulgaria
11:25-11:50		Title: Tumor Necrosis Factor-α and Interleukin-6 Levels in Patients with Primary Open-Angle Glaucoma Dr. Asaad Ahmed Ghanem, Professor, Mansoura University, Egypt
11:50-12:15		Title: Genomic Instability, Microenvironment and Telomere Homeostasis in Colorectal Carcinogenesis Dr. Pavel Vodicka, Head of the Department of Molecular Biology of Cancer, Charles University, Czech Republic
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 1-4: MicroRNAs and Long Noncoding RNAs in Cancers

Time: 09:00-11:00, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: TBD Dr. Ioannis Papasotiriou, Medical Director, R.G.C.C. INTERNATIONAL GmbH, Switzerland
09:30-09:55		Title: LncRNAs in gastroenteropancreatic neuroendocrine neoplasms. Dr. Qiyun Tang, The First Affiliated Hospital with Nanjing Medical University, China
09:55-10:20		Title: MicroRNA-17 acts as a Tumor Chemosensitizer by Targeting JAB1/CSN5 in T triple-negative Breast Cancer Dr. Sumei Wang, Associate Professor, Guangdong Provincial Hospital of Chinese Medicine, China
10:20-10:45		Speech Opportunity Available Abstract and Biography: Submit Here
10:45-11:00	Coffee Break

Track 1-5: Novel Signal Transduction Pathways in Cancer Research

Time: 14:00-16:00, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Jens Claus Hahne, Higher Scientific Officer, Laboratory of Gastrointestinal Cancer Biology and Genomics, Division of Molecular Pathology, The Institute of Cancer Research, UK
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: TBD Dr. Jens Claus Hahne, Higher Scientific Officer, Laboratory of Gastrointestinal Cancer Biology and Genomics, Division of Molecular Pathology, The Institute of Cancer Research, UK
14:30-14:55		Title: TBD Dr. A. Vieira, Associate Professor & Director of Metabolic Research Lab. BPK9625, Simon Fraser University, Canada
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break

Track 1-6: Cancer Metabolism and Metabolic Pathways

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: Multi-slice Spiral CT Exploration of Correlation Between Pathology and Other Factors in Retroperitoneal Tumors Dr. Feng Yuanchun Deputy Chief Physician, Peking University International Hospital, China
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break

Track 2-2: Cancer Epidemiology, Risk Assessment, and Control

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Mohammad R. Torabi, Chancellor’s Professor, Indiana University School of Public Health-Bloomington, USA
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: TBD Dr. Femida Gwadry-Sridhar, CEO & Founder Pulse Infoframe Inc., Canada
09:30-09:55		Title: Relationship between Obesity and Cancer: Global Perspective, Public Health Intervention Dr. Mohammad R. Torabi, Chancellor’s Professor, Indiana University School of Public Health-Bloomington, USA
09:55-10:20		Title : Epidemiology of Breast Cancer In Women Based On Diagnosis Data From Oncologists And Senologists In Algeria Dr. A Boudjella, Blida 1 University, Algeria
10:20-10:45		Speech Opportunity Available Abstract and Biography: Submit Here
10:45-11:00	Coffee Break
11:00-11:25		Title: The Big 5 Risk Behaviors for Cancers and other Chronic Diseases Dr. Janice M. Prochaska, Adjunct Professor, University of Rhode Island; Former CEO, Pro-Change Behavior Systems, Inc., Island
11:25-11:50		Title: Breakthroughs in the Prevention of Cancers and other Chronic Diseases Dr. James O. Prochaska, Director & Professor, University of Rhode Island; Founder, Pro-Change Behavior Systems, Inc., USA
11:50-12:15		Title: TBD Dr. Lisa Derendorf, University Hospital of Cologne, Germany
12:15-12:40		Title : The Epidemiology of Gastric Cancer in Tlemcen-Algeria : A Retrospective Study Dr. Dalale Behar, University Abou-Bekr Belkaid, Algeria

Track 2-3: Current and Emerging Cancer Diagnostic Technologies and Tests

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Alexander A. Oraevsky, Chief Technology Officer, TomoWave Laboratories, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: Sensitive Detection and Specific Diagnostics of Breast Cancer with Laser Optoacoustic Ultrasonic Imaging Systems Dr. Alexander A. Oraevsky, Chief Technology Officer, TomoWave Laboratories, USA
14:30-14:55		Speech Opportunity Available Abstract and Biography: Submit Here
14:55-15:20		Title: Erahertz Spectroscopy and Imaging - Cutting Edge Techniques in Gastric Cancer Diagnosis Dr. Faustino Wahaia, University of Porto, Portugal
15:20-15:45		Title:Family Genetic Peculiarities Among Women With Hereditary Breast Cancer Dr. Nataliya Kitsera, Institute of Hereditary Pathology, Ukraine
15:45-16:00	Coffee Break
16:00-16:25		Speech Opportunity Available Abstract and Biography: Submit Here
16:25-16:50		Title: Short Wave Infra-Red and Thermal Imaging of Tumors In Mice – Preliminary Results Dr. N. Blaunstein, Professor, Ben-Gurion University, Israel
16:50-17:15		Title: Rapid and Affordable Bisulfite DNA Sequencing by XmaI-reduced Representation Bisulfite Sequencing for Genome-Wide Cancer Research Mr. Alexander Tanas, Leading Researcher, Research Centre for Medical Genetics, Russia
17:15-17:40		Title: Whole-body MRI with Diffusion-Weighted Imaging---An Alternative Nonionizing Imaging Method in Pretherapeutic Assessment and Staging of Lymphomas Dr. Prachi Kala, Professor, Radiodiagnosis & Imaging, Himalayan Institute of Medical Sciences, India

Track 3-3: Robotic & Surgical Therapy

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Paul De Leyn, Chairman, UZ Leuven, Belgium
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Holographic Image Navigation in Robotic Uro-oncological Surgery or Robotic retroperitoneal lymph node Dissection with Concomitant Inferior Vena Cava Thrombectomy for Metastatic Mixed Testicular Germ Cell Cancer Dr. Gang Zhu, Professor, Beijing United Family Hospital and Clinics, China
09:30-09:55		Title: Surgical Treatment of OMD in Daily Clinical Practice Dr. Paul De Leyn, Chairman Department of Thoracic Surgery, University Hospitals Leuven, Belgium
09:55-10:20		Speech Opportunity Available Abstract and Biography: Submit Here
10:20-10:45		Title: Superior Technology of Lung Cancer Surgery: Robotic Surgery Dr. Anil Gokce, Thoracic Surgeon, University of Health Sciences, Ankara City Hospital, Turkey
10:45-11:00	Coffee Break
11:00-11:25		Title: Association of Vitamin D Receptor Start Codon Polymorphism (Fok1) rs2228570 With Mitotic Index among Breast Cancer Patients at H. Adam Malik Hospital, North Sumatera, Indonesia Dr. Kamal Basri Siregar, Consultant, Department of Oncology Surgery, H Adam Malik Hospital, Indonesia
11:25-11:50		Speech Opportunity Available Abstract and Biography: Submit Here
11:50-12:15		Title: Magnetic Ablation Dr. Jen-Jie Chieh, Professor, National Taiwan Normal University, Taiwan
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 3-4: Immunotherapy

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Ramon Simon-Lopez, Medical Director, Immucura, Switzerland
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: A Possible Key Target for Blocking Glioblastoma Progression: Chaperone-Mediated Autophagy in Pericytes Dr. Rut Valdor, University of Murcia, Spain
09:30-09:55		Title: TBD Dr. Xudong Cheng, Founder and CEO, ZSky Biotech Inc. China
09:55-10:20		Title: TBD Dr. Slawomir Lukomski, Associate Professor, West Virginia University School of Medicine, USA
10:20-10:45		Title: TBD Dr. Edwards Kasonkanji, UNC Project, Malawi
10:45-11:00	Coffee Break
11:00-11:25		Title: Plant made Vaccines to Combat COVID-19 Dr. Kathleen Hefferon, Cornell University, USA
11:25-11:50		Title: Development and Improvement of CAR-T Cell Immunotherapy for the Treatment of Mature B Cell Malignancies Dr. Beatriz Martin-Antonio, Researcher, Hospital Clinic of Barcelona/IDIBAPS, Spain
11:50-12:15		Title: Oligomeric structure of Hemocyanins as a Proof of Their Antitumor Effect, Explained through an Ezymatic Treatment Dr. Asya Daskalova, Bulgarian Academy of Sciences, Bulgaria
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 3-5: Cancer Precision Medicine and Personalized Therapy

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: TBD Dr.Leroy J. Lowe, President & Cofounder, Getting to Know Cancer, Canada
14:30-14:55		Title: Early Experience of Regional Arterial Chemoperfusion in Locally Advanced Pancreatic Carcinoma Using a New Novel Catheter Design Dr. J. Augusto Bastidas, National Surgical Associates, USA
14:55-15:20		Title: Clinical Characteristics of Patients with Liver Abscess After Radiofrequency Ablation Dr. Wendong Li, Deputy Chief Physician, Affiliated Beijing Ditan Hospital, Capital Medical University, China
15:20-15:45		Title: Image-Guided Drug Delivery and Theranostics Dr. Weibo Cai, Vilas Distinguished Achievement Professor, University of Wisconsin – Madison, USA
15:45-16:00	Coffee Break
16:00-16:25		Title : Hepatic Arterial Infusion of Oxaliplatin Combined with Capecitabine in Treatment of Liver Metastases Caused by Colon Cancer Dr. Wei Lu, Professor, The Sixth Medical Centre of PLA General Hospital, China
16:25-16:50		Title: Metastasis suppressors: What’s next in Personalized Medicine Dr. Fahd Al-Mulla, Head of the Department, Genetics and Bioinformatics, Dasman Diabetes Institute, Kuwait
16:50-17:15		Title: TBD Dr. Zhengyu LIN, Associate Professor, First Affiliated Hospital of Fujian Medical University, China
17:15-17:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 3-6: Advanced Targeted Cancer Therapies

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Rongshi Li, Professor, University of Nebraska Medical Center, USA
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Speech Opportunity Available Abstract and Biography: Submit Here
09:30-09:55		Title : Annihilation of Metastatic 4T1 Breast Tumor Micrometastases by Vascular Targeted Photodynamic Therapy with Immunomodulation Dr. Lilach Agemy, Weizmann Institute of Science, Israel
09:55-10:20		Title: Fragment-based, Structure-guided and Natural Product-derived SmallMolecules for Anticancer Drug Discovery Dr. Rongshi Li, Professor, University of Nebraska Medical Center, USA
10:20-10:45		Title: A New Immuno-Oncology Target for Colorectal Cancer Dr. Dianqing Wu, Professor, Yale University, USA
10:45-11:00	Coffee Break
11:00-11:25		Speech Opportunity Available Abstract and Biography: Submit Here
11:25-11:50		Title: TBD Dr. Tammie Wahaus, CEO, ELIAS Animal Health, LLC , USA
11:50-12:15		Title: Long Noncoding RNA CTC Inhibits Proliferation and Invasion by Targeting miR-146 to Regulate KIT in Papillary Thyroid Carcinoma Dr. Xiangtai Zeng,Director, First Affiliated Hospital of Gannan Medical University, China
12:15-12:40		Title : How to improve CAR T therapy efficacy in B cell malignicies Dr. Weidong Han, Chinese PLA General Hospital, China

Track 4-2: Anticancer Drug Delivery

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Speech Opportunity Available Abstract and Biography: Submit Here
09:30-09:55		Speech Opportunity Available Abstract and Biography: Submit Here
09:55-09:20		Speech Opportunity Available Abstract and Biography: Submit Here
09:20-09:45		Speech Opportunity Available Abstract and Biography: Submit Here
09:45-10:10	Coffee Break

Track 4-3: Anticancer Drug Candidates Toxicity and Efficacy

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Anupam Bishayee, Professor, Lake Erie College of Osteopathic Medicine, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: TBD Dr. Anupam Bishayee, Professor, Lake Erie College of Osteopathic Medicine, USA
14:55-15:20		Title: Anticancer Activity of I-DASH Inhibitors Dr. William W. Bachovchin, Professor, Tufts University School of Medicine, USA
15:20-15:45		Title: Drug Induced Inflammation Responsible for Treatment Failure Dr. Dinesh Vyas, Associate Professor, Texas Tech University, USA
15:45-16:00	Coffee Break
16:00-16:25		Title: Chromene Derivatives: A New Strategy to Overcome Renal Cancer Resistance Dr. Olivia Pontes, PhD Student, University of Minho, Portugal
16:25-16:50		Title: Association of Low Folate Status, Gene Polymorphisms And Cancer Risk Dr. Karunee Kwanbunjan, Department of Tropical Nutrition and Food Science, Faculty of Tropical Medicine, Mahidol University, Thailand
16:50-17:15		TBD Dr. Zhengyun Zou, Deputy Chief Physician, Drum Tower Hospital Affiliated to Medical College of Nanjing University, China
17:15-17:40		Title: TBD Dr. Yu-Li Lo, Taiwan, National Yang-Ming University, China

Track 5-3: Breast Cancer(Part I)

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Jana Slobodnikova, Associate Professor, Alexander Dubcek University of Trencin, Slovakia
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Breast Cancer of Young Women. Prevention, Problems of Pregnancy and Lactation. Retrospective study from Clinic of Radiology for a Period of 15 years Dr. Jana Slobodnikova, Head of the Radiology Clinic, Faculty of the Helath Care, Alexander Dubcek University in Tren�ín, Slovakia
09:30-09:55		Title: Novel Cancer Gene Variants and Gene Fusions of Triple-Negative Breast Cancers (TNBCs) Reveal Their Molecular Diversity Conserved in the Patient-Derived Xenograft (PDX) Model Dr. Jaeyun Jung, Postdoctoral Research Associate, University of Ulsan College of Medicine, Asan Medical Center, South Korea
09:55-10:20		Title: Microwave Imaging for Breast Cancer Screening Dr. Kimihito Fujii, Assistant Professor, Aichi Medical University, Japan
10:20-10:45		Title: Emotional Distress and Fatigue among Young and Older Breast Cancer Survivors Dr. Inbar Levkovich,Oranim Academic College of Education, Israel
10:45-11:00	Coffee Break
11:00-11:25		Title: Biological Activity of A Semi-Synthetic Derivative of Resveratrol in Targeting Multiple Pathways for Regulating Breast Cancer and Associated Problems Dr. Partha Roy, Professor, Indian Institute of Technology Roorkee, India
11:25-11:50		Title: Advanced in Breast Ductoscopy and Duct Lavage 1/2 Hour Dr. Stephane Zervoudis, Associated Professor, President, Mobile Mediterranean University of Mastology (MANOSMED), Greece
11:50-12:15		Title: Inflammatory Stimuli in HER-2 Dependent Evolution of Ductal Carcinoma in situ (DCIS) Dr. Hanna M. Romanska, Associate Professor, Medical University of Lodz, Poland
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 5-3: Breast Cancer(Part II)

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Speech Opportunity Available Abstract and Biography: Submit Here
09:30-09:55		Title: Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women Dr. Olivia Pagani, Coordinator of the breast cancer programme of the European School of Oncology (ESO), Breast Consultant Interdisciplinary Cancer Service Hopital Riviera-Chablais, Rennaz, Vaud (CH), Full Professor at the Medical School University of Geneva, Switzerland
09:55-10:20		Title: Breast Ductoscopy and Oncoplastic Surgery, The Current Surgical Procedures Dr. Stephane Zervoudis, Associated Professor, President, Mobile Mediterranean University of Mastology (MANOSMED), Greece
10:20-10:45		Speech Opportunity Available Abstract and Biography: Submit Here
10:45-11:00	Coffee Break
11:00-11:25		Speech Opportunity Available Abstract and Biography: Submit Here
11:25-11:50		Speech Opportunity Available Abstract and Biography: Submit Here
11:50-12:15		Title: Upregulated Cyclin A1 as Diagnostic Biomarker in Papillary Thyroid Carcinoma Dr. Renata de Azevedo Canevari, Professor, Laboratório de Biologia Molecular do Câncer, Instituto de Pesquisa e Desenvolvimento - IP&D Universidade do Vale do Paraíba – UNIVAP, Brazil
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 5-4: Gynecologic Cancer

Time: 09:00-12:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Michael Friedrich, Head, Department of Obstetrics and Gynecology, HELIOS Hospital, Germany
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: To Ablate or Not to Ablate the Endometrium In Dysfunctional Uterine Bleeding: That Is the Question Dr. Mohamed Hosni, Bradford Teaching Hospitals NHS Foundation Trust, UK
09:30-09:55		Title: TBD Dr. Chi-Min Shih, General Pathologist, Chia-Yi Hospital, Ministry of Health and Welfare, Taiwan
09:55-10:20		Speech Opportunity Available Abstract and Biography: Submit Here
10:20-10:45		Title: HIPEC and Ovarian Cancer: An Update Dr. Michael Friedrich, Head, Department of Obstetrics and Gynecology, HELIOS Hospital, Germany
10:45-11:00	Coffee Break
11:00-11:25		Title: Evaluation of the LC-1000 Flow Cytometry Screening System for Cevical Cancer Screening in Routine Health Checkups Dr. Eun-Hee Nah, Director, Health Promotion Research Institute, South Korea
11:25-11:50		Title: A Comprehensive Rehabilitation Program for Women Completing Chemo and Radiotherapy After Operation Dr. Ora Rosengarten, Shaare Zedek Medical Center, Israel
11:50-12:15		Title : HPV Catch-up Vaccination Reduces the Prevalence of HPV 16 and 18 Infections and Cervical Disease: A Retrospective Study Dr. Nick Hallam, Colposcopy Clinic Women's Outpatients Cumberland Infirmary Carlisle, UK
12:15-12:40		Title: The SNP rs4846048 of MTHFR Enhances the Cervical Cancer Risk through Association with miR-522: a Preliminary Report Dr. Jun Wang, Professor, The General Hospital of Shenyang Military Region, China

Track 5-5: Liver, Cholecyst and Pancreatic Cancer

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: TBD Dr. Mohamed Hassan, Professor, University of Strasbourg, Germany
14:30-14:55		Title: Systemic Treatments for Hepatocellular Carcinoma: Challenges and Future Perspectives Dr. Alessandro Granito, Assistant professor, University of Bologna, Italy
14:55-15:20		Title: Multiple Strategies of “Downstaging Therapy” for Hepatocellular Carcinoma Combined with Macrovascular Tumor Invasion Following Salvage Surgical Resection Dr. Jiazhou Ye, Guangxi Cancer Institute, China
15:20-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. Sen-Yung Hsieh, Professor, Chang Gung University School of Medicine, Taiwan
16:25-16:50		Title: TBD Dr. Wuyuan Zhou, Deputy Chief Physician, The Xuzhou Third People's Hospital
16:50-17:15		Title: Intraaterial Chemptherapy and Radiotherapy as Treatmnt Options in Patients with Locally Advanced Pancreatic Dr. Vladislav Moiseenko, Russia
17:15-17:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 5-6: Gastrointestinal Cancer

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Sharad Khare, Professor & Director Gastrointestinal Cancer Research, Department of Internal Medicine, University of Missouri, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: Neoadjuvant chemotherapy followed by extended surgery is effective for gastric cancer with extensive nodal disease Dr. Mitsuru Sasako, Special Consultant Surgeon, Department of Surgery, Yodogawa Christian Hospital, Japan
14:30-14:55		Title: Effect of Physical Fitness on Colorectal Tumor Development in Patients with Familial Adenomatous Polyposis Dr. Tomiyo Nakamura, Professor, Ryukoku University, Japan
14:55-15:20		Title: A Case of Brunner Gland Adenoma, Which Exhibited Dramatic Macroscopic Metamorphosis in 2 Years without Canceration Kenji Sasaki, Mori Saisei Clinic, Japan
15:20-15:45		Title: Robotic Approaches to Esophageal Resection Dr. Kenneth Meredith, Medical Director for Gastrointestinal Surgical Oncology, Florida State College of Medicine, USA
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Mr. Paul Skaife, Consultant, Liverpool University Hospitals NHS, UK
16:25-16:50		Title: A Preliminary Analysis of the Sex Distribution of Antibiotic Resistance Genes in Patients With Intrahepatic Bile Duct Stones Dr. Yanzhong Zhang, Director , Danzhou People’s Hospital, China
16:50-17:15		Speech Opportunity Available Abstract and Biography: Submit Here
17:15-17:40		Title: p73 Variants as Diagnosis and Prognosis Markers in Colorectal Cancer Patients Dr. Prieto-Nieto MI, Peritoneal Oncological Surgery Unit, Hospital La Paz, Spain

Track 6-2: Pain Management and Clinical Complications

Time: 09:00-11:00, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: The Effect of Acupuncture in Breast Cancer-Related Lymphoedema(BCRL) Dr. Tsai-Ju Chien, Hematologist and an Oncologist, Institute of Traditional Medicine, National Yang-Ming University, Taiwan
09:30-09:55		Title: Effects of Reflexology and Progressive Muscle Relaxation on Pain,Fatigue, and Quality of Life during Chemotherapy in Gynecologic Cancer Patients Dr. Fusun Terzioglu, Dean of Faculty of Health Science, Atilim University, Turkey
09:55-10:20		Speech Opportunity Available Abstract and Biography: Submit Here
10:20-10:45		Speech Opportunity Available Abstract and Biography: Submit Here
10:45-11:00	Coffee Break

Track 6-3: Psycho-oncology, Patient and Survivor Care

Time: 14:00-17:40, July 21, 2022 (Wednesday); Place: Lisbon, Portugal

Chair: Dr. Thomas Lodi, Founder & Director of Integrative Oncology, An Oasis of Healing, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: TBD Dr. Marilyn Parkin, CEO/Founder, International College of Medical Intuition, Canada
14:55-15:20		Title: TBD Dr. Kalliopi Megari, Post Doctoral Researcher, Aristotle University of Thessaloniki, Greece
15:20-15:45		Title: Efficacy and Safety of Endostar Combined with Vinorelbine and Cisplatin on the Treatment of Advanced Non-Small Cell Lung Cancer: A Comparative Study Dr. Min Guo, Hainan General Hospital, China
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. Santosh B Patel, Augusta University, USA
16:25-16:50		Speech Opportunity Available Abstract and Biography: Submit Here
16:50-17:15		Speech Opportunity Available Abstract and Biography: Submit Here
17:15-17:40		Title: Enhancing Health Literacy Among Cancer Survivors Through Open Educational Resources for Cancer in India Dr. Devi Nandakumar, Clinical Psychologist, Cancer Institute, Adyar, Chennai, India

Hosting Organization

World High Technology Society

Supporting Organization

WIN Consortium

The Society of Supportive Care in Oncology

International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Overseas Cooperate Medias and Journals